DENVER--(BUSINESS WIRE)--VieCure today announced a new collaboration with Labcorp to provide clinicians greater access to precision oncology decision support. This strategic collaboration will support ...
Illumina, Inc. (NASDAQ: ILMN) today announced that reimbursement has been granted for its FDA-approved in vitro diagnostic ...
The advent of multiomic approaches has significantly improved early cancer detection by integrating diverse molecular data to gain a more complete understanding of disease processes. While advances in ...
Making is Fueling Strong Growth in Pan-Genomic and Multi-Gene Panel Testing, Supported by Expanding NGS Access, Advanced ...
This understanding is driving a shift from isolated tests to comprehensive diagnostic panels; carefully structured groups of ...
Today, healthcare is shifting away from a one-size-fits-all approach toward personalized medicine designed around each person’s genetics, lifestyle, and health history. At St. Elizabeth Healthcare, ...
Gone are the days when oncologists reacted to a cancer diagnosis by using the few drugs we had and hoping for the best. We have evolved from being reactive to proactive, primarily due to advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback